| |
Original Artikel |
Datum |
Titel |
Autoren Max. 6 Autoren |
| 1 |
[GO] |
2025―Okt―30 |
Avoidant/Restrictive Food Intake Disorder Inappetence Subtype, Precipitated by SARS-CoV-2 Olfactory and Gustatory Impairment, Treated Successfully With Methylphenidate |
David R. Spiegel, Melanie Gonzalez-Saavedra, Melissa Hoff, Jubilee Benedict |
| 2 |
[GO] |
2025―Sep―15 |
Ketamine as a Potential Neuromodulatory Treatment for Long COVID Neuropsychiatric and Neuropathic Symptoms |
W. Michael Brode, Jacqueline Posada, Divya Nagireddy |
| 3 |
[GO] |
2025―Feb―08 |
Protracted Psychiatric Complications Including Psychosis in a Middle-Aged Man After COVID-19 Vaccination |
Seshagiri Rao Doddi, Francis Pham, Jennifer Wineke, Christopher Marano, Deborah Brooks |
| 4 |
[GO] |
2025―Jan―22 |
COVID-19 and Neuroleptic Malignant Syndrome |
Greg Noe, Kaushal Shah, Samantha Ongchuan-Martin, Sahil Munjal |
| 5 |
[GO] |
2024―Apr―19 |
A Rapid Review of the Effects of the COVID-19 Vaccine Among Individuals Taking Clozapine |
Aparna Das, Amanda T. Sawyer, Prabhava Bagla |
| 6 |
[GO] |
2024―Feb―29 |
Agomelatine as an Effective Intervention for Psychiatric Symptoms in Postacute Sequelae of COVID-19 |
Yen-An Koai, Chih-Chung Huang, Chih-Sung Liang, Ta-Chuan Yeh |
| 7 |
[GO] |
2023―Jun―24 |
Association Between Selective Serotonin Reuptake Inhibitors Prevalent Use and COVID-19-Related Mortality |
Pablo Ignacio Osores, María Noelia Vivacqua, Carolina Vazquez, Sebastián Marciano, Diego Hernán Giunta, José Luis Faccioli |
| 8 |
[GO] |
2023―Jun―14 |
Adherence to Psychotropic Medication Before and During COVID-19 |
Brandon Froese, Gian Aquino, Eunice Valencia, Qier Tan, Marina Yogendran, Cara Katz, James M. Bolton, Jamie Falk, Kaarina Kowalec, Dan Chateau, Joseph C. Delaney, Sarvesh Logsetty, Rae Spiwak, Murray W. Enns, Jitender Sareen, Silvia Alessi-Severini, Kendiss Olafson, Sherif Eltonsy, Christine Leong |
| 9 |
[GO] |
2022―Dez―30 |
Acute Psychosis After Immunization With Whole-Virion Inactivated COVID-19 Vaccine; A Case Report From Central India |
Avinash Shukla, Neethu K. Nandan, Lokesh Kumar Singh |
| 10 |
[GO] |
2022―Aug―02 |
Myocarditis After Clozapine Initiation and mRNA SARS-CoV-2 Vaccination |
Maximilian Hansbauer, Enikö Fastantz, Justina Lutz, Alkomiet Hasan |
| 11 |
[GO] |
2022―Apr―14 |
COVID-19 Outcomes: Does the Use of Psychotropic Drugs Make a Difference? Accumulating Evidence of a Beneficial Effect of Antidepressants-A Scoping Review |
Udo Bonnet, Georg Juckel |
| 12 |
[GO] |
2022―Mrz―09 |
A Decrease of Neutrophils After COVID-19 Vaccination in a Treatment-Resistant Patient With Schizophrenia Taking Clozapine |
Manabu Takaki, Yuji Yada, Shinji Sakamoto, Masaki Fujiwara, Yuko Okahisa, Norihito Yamada |
| 13 |
[GO] |
2022―Jan―29 |
Elevated Clozapine Blood Concentrations After Second COVID-19 Vaccination With Spikevax (COVID-19 Vaccine Moderna) |
Christian Knöchel, Gudrun Hefner, Thomas Stiehl, Walter Schmidbauer |
| 14 |
[GO] |
2021―Okt―20 |
A Seizure After COVID-19 Vaccination in a Patient on Clozapine |
Ahmed T. Makhlouf, Manjola U. Van Alphen, Giovanna S. Manzano, Oliver Freudenreich |
| 15 |
[GO] |
2021―Apr―13 |
Cannabidiol as a Treatment for Mental Health Outcomes Among Health Care Workers During the Coronavirus Disease Pandemic |
Júlia Cozar Pacheco, José Diogo S. Souza, Jaime E.C. Hallak, Flávia de Lima Osório, Alline C. Campos, Francisco S. Guimarães, Antonio Waldo Zuardi, José Alexandre S. Crippa |
| 16 |
[GO] |
2021―Jan―14 |
Acetaminophen (Paracetamol), COVID-19, and Misleading Conclusions |
Richard I. Shader |
| 17 |
[GO] |
2020―Okt―31 |
Psychosis Treatment During COVID-19 Pandemic and the Potential Role of Phenothiazines |
Ángel Ruiz de Pellón Santamaría |
